Explain this page
Arphra AIPlain-English read on Albany International Corp.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Quality composite
BMixed
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Profitability
Gross margin20.6%
Operating margin-1.4%
Net margin-4.8%
ROE-7.8%
ROA-3.3%
ROIC-1.4%
Liquidity & leverage
Current ratio2.10×
Quick ratio1.83×
Debt / equity0.62×
Net debt / EBITDA4.79×
Interest coverage-1×
Efficiency & per-share
Asset turnover0.69×
Inventory days47
Days sales out.73
FCF / share$2.80
Book value / share$24.76
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Headline | ||||||||
| Market cap | — | — | — | $2.5B | $1.5B | — | — | — |
| Enterprise value | — | — | — | $2.77B | $1.84B | — | — | — |
| Multiples | ||||||||
| P / E | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | 2.25 | 1.56 | — | — | — |
| EV / FCF | — | — | — | 20.04 | 22.29 | — | — | — |
| Yields | ||||||||
| Earnings yield | — | — | — | +3.51% | -3.83% | — | — | — |
| Free cash flow yield | — | — | — | +5.53% | +5.51% | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | +40.72% | +37.66% | +36.91% | +32.65% | +20.62% | +30.03% | +30.67% | +30.72% |
| Operating margin | +19.16% | +17.49% | +14.63% | +10.67% | -1.37% | +8.13% | +7.86% | +7.90% |
| EBITDA margin | +27.72% | +21.15% | +22.42% | +10.67% | +6.07% | +13.19% | +12.71% | +13.38% |
| EBIT margin | +19.73% | +14.48% | +15.73% | +10.86% | -1.37% | +8.56% | +8.58% | +8.22% |
| Pre-tax margin | +17.86% | +12.75% | +13.98% | +9.51% | -5.22% | +6.11% | +6.23% | +6.23% |
| Net margin | +12.75% | +9.25% | +9.68% | +7.12% | -4.85% | +3.96% | +3.98% | +4.05% |
| Cost structure | ||||||||
| Cost of revenue / sales | +59.28% | +62.34% | +63.09% | +67.35% | +79.38% | +70.70% | +68.79% | +68.20% |
| R&D intensity | +4.19% | +3.86% | +3.54% | +3.75% | +4.06% | +3.88% | +3.73% | +3.84% |
| SG&A intensity | +17.23% | +16.30% | +18.72% | +17.14% | +17.93% | +17.69% | +18.37% | +17.86% |
| Effective tax rate | +28.42% | +26.88% | +30.44% | +24.80% | — | +27.48% | +26.26% | +27.71% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Returns | ||||||||
| Return on equity (ROE) | +13.50% | +11.04% | +11.49% | +9.23% | -7.83% | +5.16% | +5.35% | +5.46% |
| Return on assets (ROA) | +7.61% | +5.83% | +6.06% | +5.31% | -3.34% | +2.70% | +2.64% | +2.84% |
| Return on capital (ROC) | +14.15% | +13.28% | +11.33% | +9.83% | -1.36% | +7.03% | +6.96% | +6.98% |
| Return on invested capital (ROIC) | +9.41% | +7.03% | +7.50% | +6.56% | -1.02% | +3.42% | +3.52% | +3.58% |
| Asset turnover | +59.72% | +63.02% | +62.56% | +74.64% | +68.82% | +68.16% | +66.41% | +70.01% |
| DuPont · ROE decomposition | ||||||||
| Net margin | +12.75% | +9.25% | +9.68% | +7.12% | -4.85% | +3.96% | +3.98% | +4.05% |
| Asset turnover (× revenue / assets) | +59.72% | +63.02% | +62.56% | +74.64% | +68.82% | +68.16% | +66.41% | +70.01% |
| Equity multiplier (× assets / equity) | +177.31% | +189.30% | +189.70% | +173.74% | +234.76% | +191.19% | +202.19% | +192.61% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Asset turnover | 0.60 | 0.63 | 0.63 | 0.75 | 0.69 | 0.68 | 0.66 | 0.70 |
| Fixed-asset turnover | 2.13 | 2.32 | 1.76 | 2.18 | 2.45 | — | — | — |
| Inventory turnover | 4.67 | 4.64 | 4.27 | 5.68 | 7.72 | — | — | — |
| Receivables turnover | 3.03 | 2.90 | 2.44 | 2.98 | 5.03 | — | — | — |
| Payables turnover | 7.99 | 9.25 | 8.31 | 12.54 | 14.56 | — | — | — |
| Days outstanding | ||||||||
| Days sales outstanding (DSO) | 120.39 | 125.79 | 149.47 | 122.57 | 72.54 | — | — | — |
| Days inventory outstanding (DIO) | 78.11 | 78.67 | 85.46 | 64.23 | 47.27 | — | — | — |
| Days payables outstanding (DPO) | 45.69 | 39.44 | 43.90 | 29.11 | 25.07 | — | — | — |
| Cash conversion cycle | 152.81 | 165.02 | 191.03 | 157.69 | 94.74 | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.84 | 1.34 | 1.33 | 2.49 | -2.66 | 3.70 | 3.64 | 3.68 |
| FCF / Net income | 1.38 | 0.33 | 0.58 | 1.58 | -1.44 | 2.06 | 2.00 | 1.99 |
| FCF margin | +17.62% | +3.08% | +5.62% | +11.23% | +6.99% | +8.13% | +7.95% | +8.08% |
| OCF margin | +23.40% | +12.39% | +12.90% | +17.75% | +12.89% | +14.63% | +14.48% | +14.89% |
| CapEx / Revenue | +5.78% | +9.31% | +7.28% | +6.52% | +5.90% | +6.47% | +6.63% | +6.65% |
| CapEx / D&A | 0.72 | 1.40 | 1.09 | 0.90 | 0.84 | — | — | — |
| Stock-based comp / Revenue | +0.34% | +0.44% | +1.49% | +0.38% | +0.85% | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 3.65 | 3.04 | 3.55 | 2.80 | -1.94 | 2.65 | 3.15 | 3.65 |
| EPS · basic | 3.66 | 3.06 | 3.56 | 2.81 | -1.94 | 2.62 | 3.12 | 3.71 |
| Book value / share | 27.03 | 27.58 | 30.93 | 30.28 | 24.76 | 33.77 | 34.31 | 36.13 |
| Tangible BV / share | 20.22 | 20.84 | 23.74 | 23.44 | 18.54 | 33.77 | 34.31 | 36.13 |
| Sales / share | 28.62 | 32.90 | 36.70 | 39.27 | 40.01 | 44.01 | 46.07 | 48.71 |
| Operating CF / share | 6.70 | 4.08 | 4.73 | 6.97 | 5.16 | 6.44 | 6.67 | 7.25 |
| Free cash flow / share | 5.05 | 1.01 | 2.06 | 4.41 | 2.80 | 3.58 | 3.66 | 3.94 |
| Dividends / share | 0.80 | 0.84 | 1.00 | 1.04 | 1.10 | 1.17 | 1.23 | 1.30 |
| Payout ratio | +21.86% | +27.64% | +28.04% | +37.07% | -56.64% | +66.92% | +67.26% | +65.77% |
| Retention ratio | +78.14% | +72.36% | +71.96% | +62.93% | +156.64% | +33.08% | +32.74% | +34.23% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 7y CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Top-line | |||||||||
| Revenue · YoY | — | +11.37% | +10.92% | +7.20% | -3.88% | +10.41% | +4.29% | +4.77% | +6.32% |
| Gross profit · YoY | — | +3.01% | +8.71% | -5.18% | -39.29% | +60.76% | +6.53% | +4.94% | +2.12% |
| Profit | |||||||||
| Operating income · YoY | — | +1.69% | -7.25% | -21.76% | -112.31% | +757.04% | +0.78% | +5.24% | -6.32% |
| EBITDA · YoY | — | -15.03% | +17.59% | -48.96% | -45.38% | +140.18% | +0.44% | +10.34% | -4.18% |
| Net income · YoY | — | -19.17% | +16.04% | -21.15% | -165.44% | +190.13% | +4.93% | +6.55% | -9.75% |
| Operating | |||||||||
| EBIT · YoY | — | -18.28% | +20.56% | -25.98% | -112.09% | +791.23% | +4.52% | +0.37% | -6.18% |
| R&D · YoY | — | +2.62% | +1.72% | +13.46% | +4.16% | +5.41% | +0.48% | +7.72% | +5.00% |
| Per-share | |||||||||
| EPS · diluted · YoY | — | -16.71% | +16.78% | -21.13% | -169.29% | +236.60% | +18.87% | +15.87% | 0.00% |
| EPS · basic · YoY | — | -16.39% | +16.34% | -21.07% | -169.04% | +235.24% | +19.02% | +18.70% | +0.18% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Leverage | ||||||||
| Total debt | $380.85M | $495.12M | $514.86M | $387.2M | $455.66M | $510.09M | $524.41M | $556.05M |
| Net debt | $78.82M | $203.34M | $341.44M | $271.92M | $343.31M | $360.44M | $370.28M | $398.89M |
| Net debt / EBITDA | 0.31 | 0.93 | 1.33 | 2.07 | 4.79 | 2.09 | 2.14 | 2.09 |
| Debt / equity | 0.43 | 0.57 | 0.53 | 0.41 | 0.62 | 0.51 | 0.52 | 0.53 |
| Debt / assets | +24.48% | +30.15% | +28.06% | +23.49% | +26.51% | +26.62% | +25.57% | +27.28% |
| Equity / assets | +56.40% | +52.83% | +52.71% | +57.56% | +42.60% | +52.30% | +49.46% | +51.92% |
| Coverage | ||||||||
| EBITDA / interest expense | 23.60 | 12.38 | 7.27 | 4.32 | 2.76 | 4.97 | 4.84 | 5.31 |
| Operating income / interest | 16.31 | 10.24 | 4.74 | 4.32 | -0.62 | 3.07 | 2.99 | 3.13 |
| Interest expense | $10.91M | $17.68M | $35.41M | $30.39M | $26.03M | $34.65M | $35.77M | $35.99M |
| Liquidity | ||||||||
| Current ratio | 3.65 | 3.97 | 3.53 | 3.23 | 2.10 | — | — | — |
| Quick ratio | 2.92 | 3.07 | 2.59 | 2.33 | 0.79 | — | — | — |
| Cash ratio | 1.45 | 1.38 | 0.70 | 0.51 | 0.25 | — | — | — |
| Working capital | $550.64M | $627.12M | $629.29M | $504.33M | $486.54M | — | — | — |
| Working capital / revenue | +59.26% | +60.60% | +54.82% | +40.98% | +41.13% | — | — | — |
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
Valuation
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| P / E | — | — |
| P / B | — | — |
| EV / EBITDA | — | — |
| EV / Sales | 1.56x | 2.25x |
| Earnings yield | -3.8% | 3.5% |
| FCF yield | 5.5% | 5.5% |
Returns
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
| ROE | -7.9% | 9.3% |
| ROA | -3.3% | 5.3% |
| ROIC | -1.2% | 6.9% |
Leverage & liquidity
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Debt / equity | — | — |
| Net debt / EBITDA | 4.79 | 2.07 |
| Interest coverage | — | — |
| Current ratio | 2.10x | 3.23x |
| Quick ratio | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).